Paladin phase 4 study confirms iluvien® patients' reduced need for multiple treatments

Data from the phase 4 observational real-world safety study of the intravitreal implant were presented at the annual american academy of ophthalmology (aao) conference. data from the phase 4 observational real-world safety study of the intravitreal implant were presented at the annual american academy of ophthalmology (aao) conference.
ALIM Ratings Summary
ALIM Quant Ranking